| 2025 | ||
|---|---|---|
| Gross margin | 23,6 k € | |
| EBITDA | 23,6 k € | |
| Operating profit | 20,5 k € | |
| Profit/loss | 16,2 k € | |
| Equity | 21,2 k € | |
| Total assets | 36,1 k € | |
| Cash | 51,1 € | |
| Debts | 14,9 k € | |
Source: Belgian Official Gazette
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MARC-PHARMA is a Private limited company incorporated in 2024. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Walcourt.